The Congressional Budget Office warns the new tax and spending law may trigger nearly $500 billion in Medicare cuts over 10 years via S-PAYGO sequestration, impacting providers, rural hospitals, and Medicare Advantage plans.
Hawaiʻi homeowners confront growing insurance challenges as carriers limit coverage for properties with old roofs or coastal exposure amid rising disaster risks. Learn how market dynamics and regulatory efforts shape property insurance.
Explore how Oklahoma's Strengthen Oklahoma Homes program helps homeowners with aging roofs manage insurance coverage gaps through grants for storm-resistant roof upgrades.
Raymond James starts coverage on Accelerant with an Outperform rating and $33 price target, highlighting positive market outlook and financial prospects in the insurance sector.
CMS extends the Medicare off-cycle revalidation deadline for skilled nursing facilities to January 1, 2026, maintaining the existing requirements. Providers should prepare to comply to avoid Medicare participation disruptions.
Study finds hospital involvement in Medicare ACOs does not significantly change emergency department admission rates, length of stay, or costs, suggesting current ACO models have limited impact on acute care spending.
The August 2025 EMS Financial Index from PWW Advisory Group delivers critical financial benchmarks and reimbursement trend analysis to support EMS agencies' revenue cycle management and financial stability amid changing regulations.
A Texas federal judge has denied Elevance Health's legal challenge against CMS's Medicare Advantage star ratings, reaffirming the complex regulatory framework influencing insurers' government bonus payments.
Explore how CMS's Medicare Advantage Star Rating system's opaque methodologies create regulatory arbitrage and financial risks for insurers like Elevance Health, Humana, and UnitedHealthcare, shaping the healthcare insurance landscape.
Pharmaceutical companies are adopting direct-to-consumer drug sales, bypassing insurers and PBMs. This strategy impacts drug pricing, patient out-of-pocket costs, and insurance market dynamics in the U.S.
